In clinical trials, the results were impressive: a median survival rate of 177.1 months for the early treatment Zycubo cohort compared with only 17.6 months for the untreated external cohort
There were moments of stability and hope, but the journey was also marked by setbacks
Heerspink HJL, Stefnsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, et al
Journal of the American Medical Association (JAMA)
Some safeners or antidotes protect corn, sorghum, and rice against soil-applied thiocarbamate and chloracetanilide herbicides by either increasing the levels of glutathione or by inducing activity of glutathione-dependent enzymes such as glutathione- S -transferase
These additions lack FDA approval for subcutaneous injection, and their effects on tirzepatide absorption, efficacy, and side effect profiles remain unknown